Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 2
1 (50.0%)Placebo-Controlled Study of Terpenes-Enriched Cannabis Oil T1/C28 for Children With Autism
Not Applicable
Recruiting
- Conditions
- AutismAutism Spectrum Disorder
- Interventions
- Drug: Terpenes-Enriched CBD-Predominant OilDrug: PlaceboDrug: Terpenes-Enriched CBD Oil (THC-Free)
- First Posted Date
- 2025-09-30
- Last Posted Date
- 2025-10-07
- Lead Sponsor
- Bazelet Nehushtan LtD.
- Target Recruit Count
- 78
- Registration Number
- NCT07199218
- Locations
- 🇮🇱
Shaare Zedek Medical Center, Jerusalem, N/A = Not Applicable, Israel
The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD
Phase 2
Recruiting
- Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)
- Interventions
- Drug: Oral Placebo
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Bazelet Nehushtan LtD.
- Target Recruit Count
- 120
- Registration Number
- NCT06542445
- Locations
- 🇮🇱
Shamir Medical Center, Zerifin, Israel
News
No news found